(Q33370110)

English

A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer.

scientific article

Statements

A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit